Yield10 Bioscience Begins 2020 Field Test Program to Evaluate Novel Yield Traits in Camelina and Canola
June 17 2020 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company, today announced it has begun its 2020 Field Test Program
based on the recent completion of planting at all sites contracted
for the trials in the United States and Canada. Yield10’s 2020
Field Test Program is designed to evaluate several novel traits in
Camelina and canola and the Company expects to harvest the plants
and begin reporting data from the field tests in the fourth quarter
of 2020.
“We are pleased to report that our field trial contractors
completed planting at all of the sites planned for our 2020 Field
Test Program,” said Dr. Kristi Snell, Ph.D., Chief Science Officer
of Yield10 Bioscience. “Our team will continue to work closely with
our field trial contractors as well as local consultants to monitor
our plant lines as the field tests progress through the growing
season. Our field tests are designed to generate agronomic, yield
and other data supporting the ongoing development of our traits in
Camelina, canola and other commercial crops.”
A summary of the 2020 Field Test Program:
- Camelina/C3004: C3004 is a trait designed to
increase seed yield that has shown promise in previous greenhouse
and growth chamber experiments.
- Camelina/CRISPR E3902: E3902 is a CRISPR
genome-edited trait designed to boost oil content. This line
demonstrated positive results in 2019 field tests.
- Camelina/CRISPR C3007: C3007 is a CRISPR
genome-edited trait designed to boost oil content. This is the
first season of field testing the trait.
- Camelina/C3014 and C3015: Yield10 has designed
a novel trait and reprogrammed Camelina to produce PHA biomaterial
as a third seed product. This is the first season of field tests
for the trait.
- Canola/C3004: C3004 is a trait designed to
increase seed yield. This is the first season of field testing the
trait in canola.
- Canola/C3003: Yield10 will grow 14 new
canola/C3003 commercial quality lines for seed bulk up in the field
in 2020 that the Company plans to field test in 2021. C3003 is a
seed yield trait.
In the field tests of its novel traits in Camelina and canola,
Yield10 is monitoring key agronomic and growth parameters of the
plants throughout the growth period. Yield10 also plans to evaluate
seed yield, oil content, PHA content and/or other parameters of the
traits as appropriate after seed harvest. The field tests are
designed to generate data on the performance of the novel traits
under field conditions and to advance the development of the traits
toward commercialization. The program will also generate field
grown seed for subsequent field studies.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
developing crop innovations for sustainable global food security.
The Company uses its “Trait Factory” including the “GRAIN” big data
mining trait gene discovery tool as well as the Camelina oilseed
“Fast Field Testing” system to develop high value seed traits for
the agriculture and food industries. As a path toward
commercialization of novel traits, Yield10 is pursuing a partnering
approach with major agricultural companies to drive new traits into
development for canola, soybean, corn, and other commercial crops.
The Company is also developing improved Camelina varieties as a
platform crop for the production and commercialization of
nutritional oils, proteins, and PHA biomaterials. The Company’s
expertise in oilseed crops also extends into canola, where it is
currently field-testing novel yield traits to generate data to
drive additional licensing opportunities. Yield10 is headquartered
in Woburn, MA and has an Oilseeds Center of Excellence in
Saskatoon, Canada.
For more information about the company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, statements regarding the Company’s intentions with
regard to plans to conduct field tests with Camelina and canola in
2020, the results and outcome of, and information gathered from,
those tests, the ability to use the results of the tests in future
studies or licensing activities, whether the company’s traits will
increase seed yield or boost oil content, and expectations with
regard to the timing of harvesting the plants and reporting results
of the field tests, constitute forward-looking statements. Such
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results to differ materially
from those anticipated, including the weather conditions in regions
where field tests are being conducted, which could be unfavorable
and lead to challenges in completing the tests, and other risks and
uncertainties detailed in Yield10 Bioscience's filings with the
Securities and Exchange Commission. Yield10 assumes no obligation
to update any forward-looking information contained in this press
release or with respect to the matters described herein.
Contacts: Yield10
Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations:Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024